[
  {
    "title": "灵康药业(603669.SH)：截至12月底已累计回购1.15%的股份",
    "href": "http://stock.jrj.com.cn/2023/01/05161837261342.shtml",
    "datetime": "2023-01-05 16:18:26",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：购买的信托产品发生部分逾期兑付情况",
    "href": "http://stock.jrj.com.cn/2022/12/30161637249784.shtml",
    "datetime": "2022-12-30 16:16:38",
    "code": "603669"
  },
  {
    "title": "A股异动 | 灵康药业(603669.SH)跌近7% 陶灵刚拟减持不超0.67%股份",
    "href": "http://stock.jrj.com.cn/2022/12/26094937237176.shtml",
    "datetime": "2022-12-26 09:49:42",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：陶灵刚拟减持不超0.67%股份",
    "href": "http://stock.jrj.com.cn/2022/12/23162837234337.shtml",
    "datetime": "2022-12-23 16:28:21",
    "code": "603669"
  },
  {
    "title": "【龙虎榜】灵康药业12月21日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/12/21181137229000.shtml",
    "datetime": "2022-12-21 18:11:35",
    "code": "603669"
  },
  {
    "title": "A股异动 | 灵康药业(603669.SH)涨停 已累计回购1.04%股份",
    "href": "http://stock.jrj.com.cn/2022/12/21104937227687.shtml",
    "datetime": "2022-12-21 10:49:26",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至12月16日已累计回购1.04%股份",
    "href": "http://stock.jrj.com.cn/2022/12/20165737225832.shtml",
    "datetime": "2022-12-20 16:57:10",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟改聘中审众环会计师事务所",
    "href": "http://stock.jrj.com.cn/2022/12/09184537202449.shtml",
    "datetime": "2022-12-09 18:45:42",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至11月底已累计回购0.929%股份",
    "href": "http://stock.jrj.com.cn/2022/12/05160137188776.shtml",
    "datetime": "2022-12-05 16:01:06",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东解质718万股",
    "href": "http://stock.jrj.com.cn/2022/11/22155237157486.shtml",
    "datetime": "2022-11-22 15:52:08",
    "code": "603669"
  },
  {
    "title": "【龙虎榜】灵康药业11月17日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/17180437147343.shtml",
    "datetime": "2022-11-17 18:04:23",
    "code": "603669"
  },
  {
    "title": "【龙虎榜】灵康药业11月4日成交明细",
    "href": "http://stock.jrj.com.cn/hotstock/2022/11/04180437113428.shtml",
    "datetime": "2022-11-04 18:04:33",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至10月底已累计回购387.9353万股",
    "href": "http://stock.jrj.com.cn/2022/11/03154137109680.shtml",
    "datetime": "2022-11-03 15:41:49",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东解质3416.44万股及质押2680万股",
    "href": "http://stock.jrj.com.cn/2022/09/13154936991205.shtml",
    "datetime": "2022-09-13 15:49:58",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)截至8月底已累计回购362万股",
    "href": "http://stock.jrj.com.cn/2022/09/02153436967756.shtml",
    "datetime": "2022-09-02 15:34:38",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至7月底已累计回购362万股",
    "href": "http://stock.jrj.com.cn/2022/08/02155136862879.shtml",
    "datetime": "2022-08-02 15:51:21",
    "code": "603669"
  },
  {
    "title": "灵康药业“戴维斯”双杀 集采降价顺应民心回购股票或难解下降趋势",
    "href": "http://stock.jrj.com.cn/2022/07/16070036833711.shtml",
    "datetime": "2022-07-16 07:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业“戴维斯”双杀 集采降价顺应民心回购股票或难解下降趋势",
    "href": "http://stock.jrj.com.cn/2022/07/16070036817860.shtml",
    "datetime": "2022-07-16 07:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH):灵康制药的注射用头孢美唑钠拟中标第七批全国药品集采",
    "href": "http://stock.jrj.com.cn/2022/07/13182836808196.shtml",
    "datetime": "2022-07-13 18:28:35",
    "code": "603669"
  },
  {
    "title": "灵康药业：子公司注射用头孢美唑钠拟中选第七批全国药品集中采购",
    "href": "http://stock.jrj.com.cn/2022/07/13182636808192.shtml",
    "datetime": "2022-07-13 18:26:03",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至6月底已累计回购362万股",
    "href": "http://stock.jrj.com.cn/2022/07/04155436779918.shtml",
    "datetime": "2022-07-04 15:54:52",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：2021年度权益分派10派1元 股权登记日为7月4日",
    "href": "http://stock.jrj.com.cn/2022/06/28203436765741.shtml",
    "datetime": "2022-06-28 20:34:10",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：子公司注射用头孢美唑钠通过仿制药一致性评价",
    "href": "http://stock.jrj.com.cn/2022/05/30165436689914.shtml",
    "datetime": "2022-05-30 16:54:57",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：收到关于“注射用泮托拉唑钠”药品补充申请批准通知书",
    "href": "http://stock.jrj.com.cn/2022/05/30165336689917.shtml",
    "datetime": "2022-05-30 16:53:15",
    "code": "603669"
  },
  {
    "title": "灵康药业：已回购339万股 支付总金额约2592.09万元",
    "href": "http://stock.jrj.com.cn/2022/05/06173136581730.shtml",
    "datetime": "2022-05-06 17:31:32",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)截至4月底已累计回购339万股",
    "href": "http://stock.jrj.com.cn/2022/05/06153536580234.shtml",
    "datetime": "2022-05-06 15:35:11",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：截至4月5日已累计回购161万股",
    "href": "http://stock.jrj.com.cn/2022/04/06160836262769.shtml",
    "datetime": "2022-04-06 16:08:06",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：3月29日首次回购41万股",
    "href": "http://stock.jrj.com.cn/2022/03/29160236141202.shtml",
    "datetime": "2022-03-29 16:02:31",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：选举陶灵萍为董事长",
    "href": "http://stock.jrj.com.cn/2022/03/25211235153327.shtml",
    "datetime": "2022-03-25 21:12:47",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：实控人解质419.01万股及质押的2311万股延期购回",
    "href": "http://stock.jrj.com.cn/2022/03/18160634845210.shtml",
    "datetime": "2022-03-18 16:06:20",
    "code": "603669"
  },
  {
    "title": "灵康药业将花不超6000万元回购公司股份 用于股权激励",
    "href": "http://stock.jrj.com.cn/2022/03/15183134830212.shtml",
    "datetime": "2022-03-15 18:31:36",
    "code": "603669"
  },
  {
    "title": "A股异动 | 灵康药业(603669.SH)涨4.8% 拟回购3000万至6000万元股份",
    "href": "http://stock.jrj.com.cn/2022/03/10131734808181.shtml",
    "datetime": "2022-03-10 13:17:40",
    "code": "603669"
  },
  {
    "title": "灵康药业将花不超6000万元回购公司股份 用于股权激励计划",
    "href": "http://stock.jrj.com.cn/2022/03/09195034604377.shtml",
    "datetime": "2022-03-09 19:50:41",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟3000万元-6000万元回购公司股份",
    "href": "http://stock.jrj.com.cn/2022/03/09155334545823.shtml",
    "datetime": "2022-03-09 15:53:20",
    "code": "603669"
  },
  {
    "title": "灵康药业投资首都大健康产业（北京）基金（有限合伙） 认缴出资6000万",
    "href": "http://stock.jrj.com.cn/2022/01/11190734147204.shtml",
    "datetime": "2022-01-11 19:07:16",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟斥6000万元投资首都大健康产业(北京)基金",
    "href": "http://stock.jrj.com.cn/2022/01/11154434146023.shtml",
    "datetime": "2022-01-11 15:44:26",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：灵康控股解质2204.89万股及质押2089.96万股",
    "href": "http://stock.jrj.com.cn/2021/12/21153934041565.shtml",
    "datetime": "2021-12-21 15:39:09",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：灵康控股解质1187.25万股及质押1126万股",
    "href": "http://stock.jrj.com.cn/2021/12/13154234008507.shtml",
    "datetime": "2021-12-13 15:42:20",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟以2000万元受让丙氨酰谷氨酰胺注射液(100ml：20g)上市许可等所有权益",
    "href": "http://stock.jrj.com.cn/2021/12/09164533990298.shtml",
    "datetime": "2021-12-09 16:45:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：注射用哌拉西林钠舒巴坦钠获药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/12/06155833973797.shtml",
    "datetime": "2021-12-06 15:58:51",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：注射用哌拉西林钠舒巴坦钠(4:1)获批上市",
    "href": "http://stock.jrj.com.cn/2021/12/06154133973665.shtml",
    "datetime": "2021-12-06 15:41:17",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：获财务总监张俊珂增持11.9378万股",
    "href": "http://stock.jrj.com.cn/2021/11/18182333873564.shtml",
    "datetime": "2021-11-18 18:23:52",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)第三季度净利润1010.22万元 同比下降86.72%",
    "href": "http://stock.jrj.com.cn/2021/10/29212233780079.shtml",
    "datetime": "2021-10-29 21:22:06",
    "code": "603669"
  },
  {
    "title": "灵康药业2021年前三季度净利7888.44万元 同比净利减少48.22%",
    "href": "http://stock.jrj.com.cn/2021/10/29171933778397.shtml",
    "datetime": "2021-10-29 17:19:43",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东质押的8480万股延期购回、解质300万股",
    "href": "http://stock.jrj.com.cn/2021/09/27163533524169.shtml",
    "datetime": "2021-09-27 16:35:14",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东质押的3416.44万股延期购回及解质140万股",
    "href": "http://stock.jrj.com.cn/2021/09/13154133428404.shtml",
    "datetime": "2021-09-13 15:41:52",
    "code": "603669"
  },
  {
    "title": "灵康药业2021年半年度净利6878.22万元 同比净利减少9.84%",
    "href": "http://stock.jrj.com.cn/2021/08/20204633289274.shtml",
    "datetime": "2021-08-20 20:46:55",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：上半年净利降9.84%至6878.22万元",
    "href": "http://stock.jrj.com.cn/2021/08/20162933287386.shtml",
    "datetime": "2021-08-20 16:29:26",
    "code": "603669"
  },
  {
    "title": "灵康药业：子公司签订医院药品、耗材等供应与配送合同",
    "href": "http://stock.jrj.com.cn/2021/08/11182633238506.shtml",
    "datetime": "2021-08-11 18:26:52",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：子公司山南满金与成都上锦南府医院签署长期服务协议",
    "href": "http://stock.jrj.com.cn/2021/08/11180633238392.shtml",
    "datetime": "2021-08-11 18:06:29",
    "code": "603669"
  },
  {
    "title": "灵康药业股东陶灵刚减持713.44万股 套现6734.41万",
    "href": "http://stock.jrj.com.cn/2021/07/21185133130995.shtml",
    "datetime": "2021-07-21 18:51:10",
    "code": "603669"
  },
  {
    "title": "灵康药业：股东陶灵刚累计减持1%股份 其减持计划已实施完毕",
    "href": "http://stock.jrj.com.cn/2021/07/21175733130989.shtml",
    "datetime": "2021-07-21 17:57:36",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：股东陶灵刚完成减持1%股份",
    "href": "http://stock.jrj.com.cn/2021/07/21153533129910.shtml",
    "datetime": "2021-07-21 15:35:33",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：获得产业发展扶持资金2162.98万元",
    "href": "http://stock.jrj.com.cn/2021/06/30155033021694.shtml",
    "datetime": "2021-06-30 15:50:09",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：“灵康转债”6月7日起开始转股",
    "href": "http://stock.jrj.com.cn/2021/05/31224132852804.shtml",
    "datetime": "2021-05-31 22:41:00",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：2020年度权益分派10派2元",
    "href": "http://stock.jrj.com.cn/2021/05/24165132811049.shtml",
    "datetime": "2021-05-24 16:51:22",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东质押的588万股延期购回",
    "href": "http://stock.jrj.com.cn/2021/05/19163332782066.shtml",
    "datetime": "2021-05-19 16:33:03",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669)：股东拟减持公司股份不超过713万股",
    "href": "http://stock.jrj.com.cn/2021/05/14171332755801.shtml",
    "datetime": "2021-05-14 17:13:06",
    "code": "603669"
  },
  {
    "title": "灵康药业2021年第一季度净利下滑46.82% 利息支出增加",
    "href": "http://stock.jrj.com.cn/2021/04/18101332392648.shtml",
    "datetime": "2021-04-18 10:13:24",
    "code": "603669"
  },
  {
    "title": "灵康药业2020年净利减少20.6% 总经理陶灵萍薪酬66万",
    "href": "http://stock.jrj.com.cn/2021/04/18073632392364.shtml",
    "datetime": "2021-04-18 07:36:06",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：一季度净利降46.82%至3510.65万元",
    "href": "http://stock.jrj.com.cn/2021/04/16195432388402.shtml",
    "datetime": "2021-04-16 19:54:41",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：2020年度净利降20.6%至1.6亿元 拟10派2元",
    "href": "http://stock.jrj.com.cn/2021/04/16195032388380.shtml",
    "datetime": "2021-04-16 19:50:34",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东近日合计减持1.89%股份",
    "href": "http://stock.jrj.com.cn/2021/03/25153732215748.shtml",
    "datetime": "2021-03-25 15:37:56",
    "code": "603669"
  },
  {
    "title": "灵康药业实际控制人陶灵萍质押2730.01万股 用于补充灵康控股流动资金",
    "href": "http://stock.jrj.com.cn/2021/03/18200632159021.shtml",
    "datetime": "2021-03-18 20:06:25",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：实控人陶灵萍质押2730.01万股",
    "href": "http://stock.jrj.com.cn/2021/03/18153832157035.shtml",
    "datetime": "2021-03-18 15:38:59",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：实控人解除质押3317万股",
    "href": "http://stock.jrj.com.cn/2021/03/12170432115986.shtml",
    "datetime": "2021-03-12 17:04:43",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：注射用头孢唑肟钠获批上市",
    "href": "http://stock.jrj.com.cn/2021/03/01154832050356.shtml",
    "datetime": "2021-03-01 15:48:07",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东通过大宗交易减持灵康转债52.5万张",
    "href": "http://stock.jrj.com.cn/2021/01/20165031729590.shtml",
    "datetime": "2021-01-20 16:50:36",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)控股股东大宗交易减持10%灵康转债",
    "href": "http://stock.jrj.com.cn/2021/01/11171431670936.shtml",
    "datetime": "2021-01-11 17:14:20",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康国际大厦工程主体结构顺利封顶",
    "href": "http://stock.jrj.com.cn/2021/01/07000031745810.shtml",
    "datetime": "2021-01-07 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)子公司盐酸氨溴索注射液获药品注册批件",
    "href": "http://stock.jrj.com.cn/2021/01/05184031635745.shtml",
    "datetime": "2021-01-05 18:40:01",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东减持10%“灵康转债”",
    "href": "http://stock.jrj.com.cn/2021/01/05183831635607.shtml",
    "datetime": "2021-01-05 18:38:37",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟使用不超3亿元暂时闲置募集资金进行现金管理",
    "href": "http://stock.jrj.com.cn/2020/12/31155231612614.shtml",
    "datetime": "2020-12-31 15:52:45",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：拟使用募集资金对子公司提供借款实施募投项目",
    "href": "http://stock.jrj.com.cn/2020/12/31154931612593.shtml",
    "datetime": "2020-12-31 15:49:19",
    "code": "603669"
  },
  {
    "title": "灵康药业跌停:董事长减持可转债 西南证券5天前喊持有",
    "href": "http://stock.jrj.com.cn/2020/12/24184831562945.shtml",
    "datetime": "2020-12-24 18:48:00",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东及其一致行动人减持10%“灵康转债“",
    "href": "http://stock.jrj.com.cn/2020/12/22160831545600.shtml",
    "datetime": "2020-12-22 16:08:03",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东解押2761.836万股",
    "href": "http://stock.jrj.com.cn/2020/12/18153431518577.shtml",
    "datetime": "2020-12-18 15:34:42",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：5.25亿元可转债将于12月22日起在上交所挂牌交易",
    "href": "http://stock.jrj.com.cn/2020/12/17181631510792.shtml",
    "datetime": "2020-12-17 18:16:09",
    "code": "603669"
  },
  {
    "title": "灵康药业：拟以自有资金200万元参设和沐康医药 首先切入CRO领域",
    "href": "http://stock.jrj.com.cn/2020/12/15180431495917.shtml",
    "datetime": "2020-12-15 18:04:57",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)拟200万元参与设立和沐康 打造CXO全产业链能力",
    "href": "http://stock.jrj.com.cn/2020/12/15174731495416.shtml",
    "datetime": "2020-12-15 17:47:28",
    "code": "603669"
  },
  {
    "title": "前三季业绩下降三成 研发大降六成 灵康药业控股股东质押3392万股",
    "href": "http://stock.jrj.com.cn/2020/12/11085731463391.shtml",
    "datetime": "2020-12-11 08:57:00",
    "code": "603669"
  },
  {
    "title": "灵康药业控股股东灵康控股质押3392.14万股 用于补充流动资金",
    "href": "http://stock.jrj.com.cn/2020/12/10192731458739.shtml",
    "datetime": "2020-12-10 19:27:23",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：子公司获得注射用奥美拉唑钠一致性评价受理通知书",
    "href": "http://stock.jrj.com.cn/2020/12/10153631456165.shtml",
    "datetime": "2020-12-10 15:36:14",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东质押3392.14万股",
    "href": "http://stock.jrj.com.cn/2020/12/10153631456166.shtml",
    "datetime": "2020-12-10 15:36:09",
    "code": "603669"
  },
  {
    "title": "灵康药业：下属公司注射用氟氯西林钠获《药品注册批件》",
    "href": "http://stock.jrj.com.cn/2020/12/07175031432236.shtml",
    "datetime": "2020-12-07 17:50:37",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：注射用氟氯西林钠获药品注册批件",
    "href": "http://stock.jrj.com.cn/2020/12/07153731430186.shtml",
    "datetime": "2020-12-07 15:37:34",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)可转债网上中签结果出炉：中签号共11.1928万个",
    "href": "http://stock.jrj.com.cn/2020/12/02154831393053.shtml",
    "datetime": "2020-12-02 15:48:00",
    "code": "603669"
  },
  {
    "title": "灵康药业2名股东合计质押4417万股 用于贷款担保、个人投资",
    "href": "http://stock.jrj.com.cn/2020/11/24094231335146.shtml",
    "datetime": "2020-11-24 09:42:24",
    "code": "603669"
  },
  {
    "title": "[灵康药业]实地视察小镇建设 携手共创康养未来",
    "href": "http://stock.jrj.com.cn/2020/11/20000031346506.shtml",
    "datetime": "2020-11-20 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业前三季度净利1.52亿增长1.09% 研发费用同比下滑",
    "href": "http://stock.jrj.com.cn/2020/10/31164631181452.shtml",
    "datetime": "2020-10-31 16:46:29",
    "code": "603669"
  },
  {
    "title": "灵康药业：2020年前三季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/10/30011031162984.shtml",
    "datetime": "2020-10-30 01:10:45",
    "code": "603669"
  },
  {
    "title": "[灵康药业]中国证券监督管理委员会发审委审核通过灵康药业集团公开发行可转换公司债券申请",
    "href": "http://stock.jrj.com.cn/2020/10/19000031346507.shtml",
    "datetime": "2020-10-19 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]立足萧山科技城 构筑集团发展新高地",
    "href": "http://stock.jrj.com.cn/2020/10/06000031346504.shtml",
    "datetime": "2020-10-06 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：董事王文南拟减持不超601.965万股",
    "href": "http://stock.jrj.com.cn/2020/09/25185430836878.shtml",
    "datetime": "2020-09-25 18:54:52",
    "code": "603669"
  },
  {
    "title": "灵康药业(603669.SH)：控股股东质押8780万股",
    "href": "http://stock.jrj.com.cn/2020/09/25185430836879.shtml",
    "datetime": "2020-09-25 18:54:10",
    "code": "603669"
  },
  {
    "title": "灵康药业：本次可转债募集资金用于投资建设海南灵康制药美安生产基地建设项目",
    "href": "http://stock.jrj.com.cn/2020/09/22160130810115.shtml",
    "datetime": "2020-09-22 16:01:32",
    "code": "603669"
  },
  {
    "title": "[灵康药业]海南生产基地顺利开展2020年院士团队创新中心产学研交流活动",
    "href": "http://stock.jrj.com.cn/2020/09/09000031346503.shtml",
    "datetime": "2020-09-09 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]首届心脑神经疾病基础研究与前沿转化论坛在京举办瑞立速注射用石杉碱甲引发关注",
    "href": "http://stock.jrj.com.cn/2020/09/04000030818120.shtml",
    "datetime": "2020-09-04 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]热烈祝贺灵康控股集团连续九年上榜浙商全国500强",
    "href": "http://stock.jrj.com.cn/2020/08/26000030818117.shtml",
    "datetime": "2020-08-26 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]海南灵康制药有限公司荣获“2020年海口市民营企业100强”称号",
    "href": "http://stock.jrj.com.cn/2020/08/14000030818118.shtml",
    "datetime": "2020-08-14 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业2020年上半年净利7629.23万下滑30.33% 销售收入下降",
    "href": "http://stock.jrj.com.cn/2020/08/07204830451935.shtml",
    "datetime": "2020-08-07 20:48:57",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康控股集团与蓝城集团正式合作签约",
    "href": "http://stock.jrj.com.cn/2020/08/04000030818119.shtml",
    "datetime": "2020-08-04 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东陶灵刚减持713万股 套现约6710万元",
    "href": "http://stock.jrj.com.cn/2020/07/31213630396227.shtml",
    "datetime": "2020-07-31 21:36:37",
    "code": "603669"
  },
  {
    "title": "灵康药业：2020年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2020/06/11224029902473.shtml",
    "datetime": "2020-06-11 22:40:06",
    "code": "603669"
  },
  {
    "title": "灵康药业：关于召开2020年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/05/26221129770983.shtml",
    "datetime": "2020-05-26 22:11:28",
    "code": "603669"
  },
  {
    "title": "灵康药业：第三届董事会第七次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/05/26221129770982.shtml",
    "datetime": "2020-05-26 22:11:27",
    "code": "603669"
  },
  {
    "title": "灵康药业独立董事王涌辞职 2019年薪酬为10万元",
    "href": "http://stock.jrj.com.cn/2020/05/21190129732680.shtml",
    "datetime": "2020-05-21 19:01:13",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2020/05/20003029715242.shtml",
    "datetime": "2020-05-20 00:30:14",
    "code": "603669"
  },
  {
    "title": "灵康药业：与海南省肿瘤医院战略合作",
    "href": "http://stock.jrj.com.cn/2020/05/07174529611414.shtml",
    "datetime": "2020-05-07 17:45:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：拟与海南肿瘤医院战略合作 有助于提升公司业务发展空间",
    "href": "http://stock.jrj.com.cn/2020/05/07163929610410.shtml",
    "datetime": "2020-05-07 16:39:02",
    "code": "603669"
  },
  {
    "title": "灵康药业：与海南省肿瘤医院签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2020/05/07163029610370.shtml",
    "datetime": "2020-05-07 16:30:31",
    "code": "603669"
  },
  {
    "title": "[灵康药业]2020年一季度业绩稳步发展战略布局再受关注",
    "href": "http://stock.jrj.com.cn/2020/04/28000029792017.shtml",
    "datetime": "2020-04-28 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2020年第一季度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/21233029341965.shtml",
    "datetime": "2020-04-21 23:30:07",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2020/04/18002029316605.shtml",
    "datetime": "2020-04-18 00:20:01",
    "code": "603669"
  },
  {
    "title": "灵康药业：第三届董事会第五次会议决议公告",
    "href": "http://stock.jrj.com.cn/2020/04/18002029316606.shtml",
    "datetime": "2020-04-18 00:20:01",
    "code": "603669"
  },
  {
    "title": "灵康药业：关于召开2019年年度股东大会的通知",
    "href": "http://stock.jrj.com.cn/2020/04/18002029316607.shtml",
    "datetime": "2020-04-18 00:20:01",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年净利同比增10% 拟10转4派2元",
    "href": "http://stock.jrj.com.cn/2020/04/17215829315968.shtml",
    "datetime": "2020-04-17 21:58:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]海南生产基地绩效考核工作持续深化",
    "href": "http://stock.jrj.com.cn/2020/04/03000029792016.shtml",
    "datetime": "2020-04-03 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]丽水市委副书记市长吴晓东到灵康—丽水“杏福康旅小镇”实地调研",
    "href": "http://stock.jrj.com.cn/2020/03/20000029790860.shtml",
    "datetime": "2020-03-20 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团股份有限公司2020 年工作会议在杭州顺利召开",
    "href": "http://stock.jrj.com.cn/2020/03/10000029119522.shtml",
    "datetime": "2020-03-10 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]海口国家高新区领导调研指导企业复工复产工作",
    "href": "http://stock.jrj.com.cn/2020/03/02000029792018.shtml",
    "datetime": "2020-03-02 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]战略发展与转型创新",
    "href": "http://stock.jrj.com.cn/2020/02/25000028890174.shtml",
    "datetime": "2020-02-25 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东陶灵刚减持430.25万股 权益变动后持股比例为3.38%",
    "href": "http://stock.jrj.com.cn/2020/02/05210528778179.shtml",
    "datetime": "2020-02-05 21:05:37",
    "code": "603669"
  },
  {
    "title": "灵康药业捐赠300多万元药品驰援武汉疫区",
    "href": "http://stock.jrj.com.cn/2020/01/28211428739863.shtml",
    "datetime": "2020-01-28 21:14:24",
    "code": "603669"
  },
  {
    "title": "灵康药业：公司两种对各类肺炎有治疗作用的抗微生物产品发往武汉",
    "href": "http://stock.jrj.com.cn/2020/01/26215428736818.shtml",
    "datetime": "2020-01-26 21:54:34",
    "code": "603669"
  },
  {
    "title": "灵康药业：公司两种对各类肺炎有治疗作用的抗微生物产品发往武汉",
    "href": "http://stock.jrj.com.cn/2020/01/26214828736816.shtml",
    "datetime": "2020-01-26 21:48:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团 2019 年度中高层管理干部述职报告会顺利召开",
    "href": "http://stock.jrj.com.cn/2020/01/16000029119523.shtml",
    "datetime": "2020-01-16 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]国家医保局、人力资源社会保障部印发2019年国家医保谈判准入药品名单",
    "href": "http://stock.jrj.com.cn/2019/12/23000028573566.shtml",
    "datetime": "2019-12-23 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业前三季度盈利1.51亿 同比下滑9.28%",
    "href": "http://stock.jrj.com.cn/2019/10/26091828303590.shtml",
    "datetime": "2019-10-26 09:18:48",
    "code": "603669"
  },
  {
    "title": "[灵康药业]深化产业合作,共推医疗大健康生态圈发展",
    "href": "http://stock.jrj.com.cn/2019/09/30000028214913.shtml",
    "datetime": "2019-09-30 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康控股集团受邀参加2019第二届世界丽水人大会",
    "href": "http://stock.jrj.com.cn/2019/09/30000028412814.shtml",
    "datetime": "2019-09-30 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年半年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2019/09/26234028186968.shtml",
    "datetime": "2019-09-26 23:40:09",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团2019年第二次临时股东大会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/09/24000028412815.shtml",
    "datetime": "2019-09-24 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团投资的博鳌超级医院再获国家多项突破性政策",
    "href": "http://stock.jrj.com.cn/2019/09/23000028412813.shtml",
    "datetime": "2019-09-23 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年第二次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/09/21001028161750.shtml",
    "datetime": "2019-09-21 00:10:01",
    "code": "603669"
  },
  {
    "title": "灵康药业：投资的博鳌超级医院首批进入博鳌乐城国际医疗旅游先行区",
    "href": "http://stock.jrj.com.cn/2019/09/17201828141839.shtml",
    "datetime": "2019-09-17 20:18:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东陶灵刚拟减持股份 预计减持不超总股本0.84%",
    "href": "http://stock.jrj.com.cn/2019/09/08200228105578.shtml",
    "datetime": "2019-09-08 20:02:32",
    "code": "603669"
  },
  {
    "title": "灵康药业：持股4.22%的股东拟减持不超0.84%",
    "href": "http://stock.jrj.com.cn/2019/09/06170028101720.shtml",
    "datetime": "2019-09-06 17:00:59",
    "code": "603669"
  },
  {
    "title": "灵康药业：股东拟减持不超过430万股 占比0.84％",
    "href": "http://stock.jrj.com.cn/2019/09/06165628101695.shtml",
    "datetime": "2019-09-06 16:56:19",
    "code": "603669"
  },
  {
    "title": "上半年净利润同比增近六成 灵康药业涨停",
    "href": "http://stock.jrj.com.cn/2019/09/02095428074255.shtml",
    "datetime": "2019-09-02 09:54:36",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2019/08/31081028070854.shtml",
    "datetime": "2019-08-31 08:10:14",
    "code": "603669"
  },
  {
    "title": "灵康药业：第三届董事会第三次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/08/31081028070855.shtml",
    "datetime": "2019-08-31 08:10:14",
    "code": "603669"
  },
  {
    "title": "灵康药业：关于召开2019年第二次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/08/31081028070856.shtml",
    "datetime": "2019-08-31 08:10:14",
    "code": "603669"
  },
  {
    "title": "灵康药业上半年净利润同比增近六成",
    "href": "http://stock.jrj.com.cn/2019/08/30210828069984.shtml",
    "datetime": "2019-08-30 21:08:01",
    "code": "603669"
  },
  {
    "title": "灵康药业2019年上半年净利1.09亿 较上年同期增长58%",
    "href": "http://stock.jrj.com.cn/2019/08/30195228068599.shtml",
    "datetime": "2019-08-30 19:52:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]丽水市莲都区“灵康杯”第四届万步有约健走激励大赛顺利开展",
    "href": "http://stock.jrj.com.cn/2019/08/20000028367294.shtml",
    "datetime": "2019-08-20 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]丽水市莲都区“灵康杯”2019男子职工篮球赛火热开幕",
    "href": "http://stock.jrj.com.cn/2019/08/15000028367295.shtml",
    "datetime": "2019-08-15 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]酷暑送清凉 丝丝暖人心",
    "href": "http://stock.jrj.com.cn/2019/08/01000027916718.shtml",
    "datetime": "2019-08-01 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团股份有限公司2019年半年度销售工作会议顺利召开",
    "href": "http://stock.jrj.com.cn/2019/07/29000027898823.shtml",
    "datetime": "2019-07-29 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业销售费用问题凸显 利好消息下大股东减持为哪般？",
    "href": "http://stock.jrj.com.cn/2019/07/20103927865545.shtml",
    "datetime": "2019-07-20 10:39:12",
    "code": "603669"
  },
  {
    "title": "灵康药业：获得产业发展扶持资金3681万元",
    "href": "http://stock.jrj.com.cn/2019/07/02155327786115.shtml",
    "datetime": "2019-07-02 15:53:44",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团 2019 年第一次区域性销售工作会议顺利召开",
    "href": "http://stock.jrj.com.cn/2019/06/24000027769353.shtml",
    "datetime": "2019-06-24 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]“灵康——杏福康旅小镇”被列入浙江省“五个千亿”投资工程",
    "href": "http://stock.jrj.com.cn/2019/06/18000027769352.shtml",
    "datetime": "2019-06-18 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：奥扎格雷钠注射液获得药品注册批件",
    "href": "http://stock.jrj.com.cn/2019/06/17154627714849.shtml",
    "datetime": "2019-06-17 15:46:14",
    "code": "603669"
  },
  {
    "title": "灵康药业：年报推10转4派4.5元 股权登记6月5日",
    "href": "http://stock.jrj.com.cn/2019/05/29182527638321.shtml",
    "datetime": "2019-05-29 18:25:01",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康控股与中核核素签署战略合作协议",
    "href": "http://stock.jrj.com.cn/2019/05/29000027663358.shtml",
    "datetime": "2019-05-29 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团2018年年度股东大会在杭州顺利召开",
    "href": "http://stock.jrj.com.cn/2019/05/27000027663357.shtml",
    "datetime": "2019-05-27 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2018年年度股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/05/18131027589062.shtml",
    "datetime": "2019-05-18 13:10:13",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团2019年第一次临时股东大会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/05/07000027537133.shtml",
    "datetime": "2019-05-07 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]总结反思提效率 规划展望强作风",
    "href": "http://stock.jrj.com.cn/2019/05/07000027537135.shtml",
    "datetime": "2019-05-07 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]勤思敏行 行稳致远 锐意精进 逐梦不息",
    "href": "http://stock.jrj.com.cn/2019/05/07000027537134.shtml",
    "datetime": "2019-05-07 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业去年净利1.83亿同比增长13% 董事长陶灵萍薪酬为66万元",
    "href": "http://stock.jrj.com.cn/2019/04/29231527509689.shtml",
    "datetime": "2019-04-29 23:15:08",
    "code": "603669"
  },
  {
    "title": "灵康药业控股股东一致行动人陶灵刚违规减持股份 上交所下发监管函",
    "href": "http://stock.jrj.com.cn/2019/04/23154427466555.shtml",
    "datetime": "2019-04-23 15:44:09",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团应邀参加长三角工商峰会",
    "href": "http://stock.jrj.com.cn/2019/04/18000027633516.shtml",
    "datetime": "2019-04-18 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]日本SANK医药企业代表三谷宜郷一行到访灵康药业集团",
    "href": "http://stock.jrj.com.cn/2019/04/13000027633515.shtml",
    "datetime": "2019-04-13 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]医疗器械临床评价协调项目成果文件草案获IMDRF管委会全票通过并向全球公开征求意见",
    "href": "http://stock.jrj.com.cn/2019/03/23000027542349.shtml",
    "datetime": "2019-03-23 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]“凤凰行动·浙商股道行”",
    "href": "http://stock.jrj.com.cn/2019/03/19000027633514.shtml",
    "datetime": "2019-03-19 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东陶灵刚减持90万股 套现905万元",
    "href": "http://stock.jrj.com.cn/2019/03/12075327152131.shtml",
    "datetime": "2019-03-12 07:53:35",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团2019年第一次临时股东大会顺利召开",
    "href": "http://stock.jrj.com.cn/2019/03/05000028068244.shtml",
    "datetime": "2019-03-05 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2019年第一次临时股东大会决议公告",
    "href": "http://stock.jrj.com.cn/2019/02/28221027103429.shtml",
    "datetime": "2019-02-28 22:10:18",
    "code": "603669"
  },
  {
    "title": "灵康药业：第三届董事会第一次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/02/28221027103428.shtml",
    "datetime": "2019-02-28 22:10:17",
    "code": "603669"
  },
  {
    "title": "[灵康药业]勤思敏行 行稳致远 锐意精进 逐梦不息",
    "href": "http://stock.jrj.com.cn/2019/02/21000028068242.shtml",
    "datetime": "2019-02-21 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]总结反思提效率 规划展望强作风",
    "href": "http://stock.jrj.com.cn/2019/02/20000028068243.shtml",
    "datetime": "2019-02-20 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：第二届董事会第二十次会议决议公告",
    "href": "http://stock.jrj.com.cn/2019/02/01220027014724.shtml",
    "datetime": "2019-02-01 22:00:20",
    "code": "603669"
  },
  {
    "title": "灵康药业：关于召开2019年第一次临时股东大会的通知",
    "href": "http://stock.jrj.com.cn/2019/02/01220027014725.shtml",
    "datetime": "2019-02-01 22:00:20",
    "code": "603669"
  },
  {
    "title": "[灵康药业]热烈祝贺灵康药业集团“注射用奥美拉唑钠”再获嘉彰",
    "href": "http://stock.jrj.com.cn/2018/12/31000027296538.shtml",
    "datetime": "2018-12-31 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]热烈祝贺灵康国际大厦顺利开工",
    "href": "http://stock.jrj.com.cn/2018/12/31000027296541.shtml",
    "datetime": "2018-12-31 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：子公司获得氟马西尼注射液注册批件",
    "href": "http://stock.jrj.com.cn/hotstock/2018/12/28075926817342.shtml",
    "datetime": "2018-12-28 07:59:58",
    "code": "603669"
  },
  {
    "title": "灵康药业：股东拟减持不超0.87%股份",
    "href": "http://stock.jrj.com.cn/2018/11/15173625350364.shtml",
    "datetime": "2018-11-15 17:36:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东灵康控股补充质押761万股",
    "href": "http://stock.jrj.com.cn/2018/11/09105925322708.shtml",
    "datetime": "2018-11-09 10:59:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]紧抓合作机遇 铺就共赢之路",
    "href": "http://stock.jrj.com.cn/2018/10/31000027296540.shtml",
    "datetime": "2018-10-31 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康 - 丽水“杏福康旅小镇”项目正式签约",
    "href": "http://stock.jrj.com.cn/2018/10/31000027296539.shtml",
    "datetime": "2018-10-31 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：前三季度净利1.66亿元 同比增逾7成",
    "href": "http://stock.jrj.com.cn/2018/10/26205625265932.shtml",
    "datetime": "2018-10-26 20:56:00",
    "code": "603669"
  },
  {
    "title": "灵康药业股东灵康控股向浙商证券补充质押320万股 占其所持1.78%",
    "href": "http://stock.jrj.com.cn/2018/10/20164025231275.shtml",
    "datetime": "2018-10-20 16:40:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]2018年中欧药品工作组会议在杭州召开",
    "href": "http://stock.jrj.com.cn/2018/10/13000027542348.shtml",
    "datetime": "2018-10-13 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]浙江灵康控股有限公司荣登“2018 浙商全国 500 强”",
    "href": "http://stock.jrj.com.cn/2018/08/31000027296537.shtml",
    "datetime": "2018-08-31 00:00:00",
    "code": "603669"
  },
  {
    "title": "收购海南省肿瘤医院成美国际25%股权 灵康药业涨停",
    "href": "http://stock.jrj.com.cn/2018/08/22093324984709.shtml",
    "datetime": "2018-08-22 09:33:56",
    "code": "603669"
  },
  {
    "title": "灵康药业1亿元收购成美国际25%股权 首次进军高端医疗",
    "href": "http://stock.jrj.com.cn/2018/08/21173424982018.shtml",
    "datetime": "2018-08-21 17:34:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：1亿元收购海南省肿瘤医院成美国际25%股权",
    "href": "http://stock.jrj.com.cn/2018/08/21172024981920.shtml",
    "datetime": "2018-08-21 17:20:12",
    "code": "603669"
  },
  {
    "title": "灵康药业：2018年半年度主要财务指标",
    "href": "http://stock.jrj.com.cn/2018/08/10215024939362.shtml",
    "datetime": "2018-08-10 21:50:08",
    "code": "603669"
  },
  {
    "title": "灵康药业：第二届董事会第十八次会议决议公告",
    "href": "http://stock.jrj.com.cn/2018/08/10215024939363.shtml",
    "datetime": "2018-08-10 21:50:08",
    "code": "603669"
  },
  {
    "title": "灵康药业：实控人未发生变更",
    "href": "http://stock.jrj.com.cn/2018/07/17170024825829.shtml",
    "datetime": "2018-07-17 17:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]“杏福健康小镇”项目签约丽水莲都",
    "href": "http://stock.jrj.com.cn/2018/06/30000028068228.shtml",
    "datetime": "2018-06-30 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]“杏福健康小镇”项目签约丽水莲都",
    "href": "http://stock.jrj.com.cn/2018/06/30000027292974.shtml",
    "datetime": "2018-06-30 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：销售网络已覆盖逾3500家二级以上医院",
    "href": "http://stock.jrj.com.cn/2018/06/22153124716131.shtml",
    "datetime": "2018-06-22 15:31:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：首次公开发行限售股上市流通公告",
    "href": "http://stock.jrj.com.cn/2018/05/23235024581689.shtml",
    "datetime": "2018-05-23 23:50:09",
    "code": "603669"
  },
  {
    "title": "灵康药业：拟1亿元入股海南肿瘤医院旗下医疗机构",
    "href": "http://stock.jrj.com.cn/2018/05/08201524511665.shtml",
    "datetime": "2018-05-08 20:15:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]热烈祝贺灵康药业集团西藏山南总部大楼建设顺利开工!",
    "href": "http://stock.jrj.com.cn/2018/05/04000024494695.shtml",
    "datetime": "2018-05-04 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：2017年年度权益分派实施公告",
    "href": "http://stock.jrj.com.cn/2018/05/02235024483336.shtml",
    "datetime": "2018-05-02 23:50:05",
    "code": "603669"
  },
  {
    "title": "[灵康药业]团结凝聚力量 实干创造希望",
    "href": "http://stock.jrj.com.cn/2018/04/23000024441880.shtml",
    "datetime": "2018-04-23 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]顺势而为争朝夕 逆风扬帆铸铁军",
    "href": "http://stock.jrj.com.cn/2018/04/23000024441877.shtml",
    "datetime": "2018-04-23 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]市场监管总局挂牌 食药安全开启新征程",
    "href": "http://stock.jrj.com.cn/2018/04/12000024381508.shtml",
    "datetime": "2018-04-12 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]国务院办公厅印发《关于改革完善仿制药供应保障及使用政策的意见》",
    "href": "http://stock.jrj.com.cn/2018/04/12000024381509.shtml",
    "datetime": "2018-04-12 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]拓展国际合作 共赢未来发展",
    "href": "http://stock.jrj.com.cn/2018/03/27000024381855.shtml",
    "datetime": "2018-03-27 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：年报净利增4.6% 拟10转4派4元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/03/26075924296629.shtml",
    "datetime": "2018-03-26 07:59:54",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团“海南院士工作站”成功举行揭牌仪式",
    "href": "http://stock.jrj.com.cn/2018/02/12000024107390.shtml",
    "datetime": "2018-02-12 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]创新,企业发展壮大的不竭动力",
    "href": "http://stock.jrj.com.cn/2018/02/12000024107394.shtml",
    "datetime": "2018-02-12 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：收到政府补助1922万元",
    "href": "http://stock.jrj.com.cn/hotstock/2018/01/02090423881330.shtml",
    "datetime": "2018-01-02 09:04:58",
    "code": "603669"
  },
  {
    "title": "[灵康药业]灵康药业集团股份有限公司2017年半年度销售工作会议在杭州顺利召开",
    "href": "http://stock.jrj.com.cn/2017/12/05000023741586.shtml",
    "datetime": "2017-12-05 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]深入实际做调研 团结一心促发展",
    "href": "http://stock.jrj.com.cn/2017/12/05000023741584.shtml",
    "datetime": "2017-12-05 00:00:00",
    "code": "603669"
  },
  {
    "title": "[灵康药业]热烈祝贺长江商学院CK1912雄飞队杭州拓展活动圆满落幕",
    "href": "http://stock.jrj.com.cn/2017/12/05000023741585.shtml",
    "datetime": "2017-12-05 00:00:00",
    "code": "603669"
  },
  {
    "title": "灵康药业：收到2100万元政府补助金",
    "href": "http://stock.jrj.com.cn/hotstock/2016/06/24075921108462.shtml",
    "datetime": "2016-06-24 07:59:55",
    "code": "603669"
  },
  {
    "title": "灵康药业等9家公司预先披露更新招股书",
    "href": "http://stock.jrj.com.cn/ipo/2015/03/11190218949842.shtml",
    "datetime": "2015-03-11 19:02:23",
    "code": "603669"
  },
  {
    "title": "灵康药业等9家公司预先披露更新",
    "href": "http://stock.jrj.com.cn/ipo/2015/03/11190218949841.shtml",
    "datetime": "2015-03-11 19:02:17",
    "code": "603669"
  },
  {
    "title": "灵康药业频陷“质量门” 上市前夕补贴飙升近一倍",
    "href": "http://stock.jrj.com.cn/ipo/2014/08/22084117863252.shtml",
    "datetime": "2014-08-22 08:41:53",
    "code": "603669"
  }
]